Therapeutic Strategies for B Cell Malignancies Involving Idiotype-Anti-idiotype Interactions

References

• Stevenson G. T., Stevenson F. K. Antibody to a Molecularly-defined Antigen Confined to a Tumor Cell Surface. Nature 1975; 254: 714–716
   PubMed Web of Science ®Google Scholar
• Stevenson G. T., Elliott E. V., Stevenson F. K. Idiotypic Determinants on the Surface Immunoglobulin of Neoplastic Lymphocytes: A Therapeutic Target. Fed. Proc. 1977; 36: 2268–2271
   PubMedGoogle Scholar
• Haughton G., Lanier L. L., Babcock G. F., Lynes M. A. Antigen-induced Murine B Cell Lymphomas. II. Exploitation of the Surface Idiotype as Tumor Specific Antigen. J. Immunol. 1978; 121: 2358–2362
   PubMed Web of Science ®Google Scholar
• Krolick K. A., Isakson P. C., Uhr J. W., Vitetta E. S. BCL1, a Murine Model for Chronic Lymphocytic Leukaemia: Use of the Surface Immunoglobulin Idiotype for the Detection and Treatment of Tumor. Immunology. Rev. 1979; 48: 81–106
   PubMed Web of Science ®Google Scholar
• Hamblin T. J., Abdul-Ahad A. K., Gordon J., Stevenson F. K., Stevenson G. T. Preliminary Experience in Treating Lymphocytic Leukaemia with Antibody to Immunoglobulin Idiotypes on the Cell Surfaces. Brit. J. Cancer 1980; 42: 495–502
   PubMed Web of Science ®Google Scholar
• Miller R. A., Maloney D. G., Warnke R., Levy R. Treatment of B-Cell Lymphoma with Monoclonal Anti-idiotype Antibody. N. Engl. J. Med. 1982; 306: 517–522
   PubMed Web of Science ®Google Scholar
• Meeker T. C., Lowder J., Maloney D. G., Miller R. A., Thielemans K., Warnke R., Levy R. A Clinical Trial of Anti-Idiotype Therapy for B Cell Malignancy. Blood 1985; 65: 1349–1363
   PubMed Web of Science ®Google Scholar
• Gordon J., Abdul-Ahad A. K., Hamblin T. J., Stevenson F. K., Stevenson G. T. Mechanisms of Tumor Cell Escape Encountered in Treating Lymphocytic Leukaemia with Anti-Idiotypic Antibody. Brit. J. Cancer 1984; 49: 547–557
   PubMedGoogle Scholar
• Meeker T., Lowder J., Cleary M. L., Stewart S., Warnke R., Sklar J., Levy R. Emergence of Idiotype Variants During Treatment of B-Cell Lymphoma with Anti-Idiotype Antibodies. N. Engl. J. Med. 1985; 312: 1658–1665
   PubMed Web of Science ®Google Scholar
• Cawley J. C., Burns G. F., Bevan A., Worman C. P., Smith J. L., Gray L., Barker C. R., Hayhoe F. G. J. Typical Hairy-Cell Leukaemia with IgGk Paraproteinaemia. Brit. J. Haematol. 1979; 43: 215–221
   PubMed Web of Science ®Google Scholar
• Quesada J. R., Reuben J., Manning J. T., Hersch E. M., Gutterman J. U. Alpha Interferon for Induction of Remission in Hairy-Cell Leukaemia. N. Engl. J. Med. 1984; 310: 15–18
   PubMed Web of Science ®Google Scholar
• Lynch R. G., Rohrer J. W., Odermatt B., Gebel H. M., Autry J. R., Hoover R. G. Immunoregulation of Murine Myeloma Cell Growth and Differentiation: A Monoclonal Model of B Cell Differentiation. Immunol. Rev. 1979; 48: 45–80
   PubMed Web of Science ®Google Scholar
• Sugai S., Palmer D. W., Talal N., Witz I. P. Protective and Cellular Immune Responses to Idiotypic Determinants on Cells from a Spontaneous Lymphoma of NZB/NZW F1 Mice. J. Exp. Med. 1974; 140: 1547–1558
   PubMedGoogle Scholar
• Jerne N. K. Towards a Network Theory of the Immune System. Ann. Immunol. (Inst. Pasteur) 1974; 125C: 373–389
   PubMedGoogle Scholar
• Capra J. D. Towards a Chemical Definition of Idiotypy. Fed. Proc. 1977; 36: 204–206
   PubMedGoogle Scholar
• Williamson A. R. The Biological Origin of Antibody Diversity. Ann. Rev. Biochem. 1976; 45: 467–500
   PubMed Web of Science ®Google Scholar
• Lennert K., Stein H. Histopathology of Non-Hodgkin's Lymphomas. Springer Verlag, Berlin 1981
   Google Scholar
• Stevenson F. K., Hamblin T. J., Stevenson G. T. The Nature of the Immunoglobulin G on the Surfaces of B Lymphocytes in Chronic Lymphocytic Leukaemia. J. Exp. Med. 1981; 154: 1965–1969
   Google Scholar
• Stevenson F. K., Gregg E. O., Smith J. L., Stevenson G. T. Secretion of Immunoglobulin by Neoplastic B Lymphocytes from Lymph Nodes of Patients with Lymphoma. Brit. J. Cancer 1984; 50: 579–586
   Google Scholar
• Eisen H. N., Sakato N., Hall S. J. Myeloma proteins as Tumor-Specific Antigens. Transplant. Proc. 1975; 7: 209–214
   PubMed Web of Science ®Google Scholar
• Stevenson F. K., Hamblin T. J., Stevenson G. T., Tutt A. L. Extracellular Idiotypic Immunoglobulin Arising from Human Leukemic B Lymphocytes. J. Exp. Med. 1980; 152: 1484–1496
   PubMed Web of Science ®Google Scholar
• Thielemans K., Maloney D. G., Meeker T., Fugimoto J., Doss C., Warnke R. A., Bindl J., Gralow J., Miller R. A., Levy R. Strategies for Production of Monoclonal Anti-Idiotype Antibodies Against Human B Cell Lymphomas. J. Immunol., 133: 495–501
   Google Scholar
• Rankin E. M., Hekman A., van Leeuwenhoekhuis A. Shared Idiotypes Among Surface Immunoglobulins in Non-Hodgkin's Lymphoma. N. Engl. J. Med. 1984; 311: 470–471
   Google Scholar
• Stevenson G. T., Smith J. L., Hamblin T. J. Immunological Investigation of Lymphoid Neoplasms. Churchill Livingstone, Edinburgh 1983
   Google Scholar
• Croce C. M., Shander M., Martinis J., Cicurel L., O'Ancona G. G., Koprowski H. Preferential Retention of Human Chromosome 14 in Mouse x Human B Cell Hybrids. Eur. J. Immunol 1980; 10: 486–488
   Web of Science ®Google Scholar
• Foung S. K. H., Perkins S., Raubitschet A., Larrick J., Lizak G., Fishwild D., Engleman E. G., Grumet F. C. Rescue of Human Monoclonal Antibody Production from an EBV-transformed B Cell Line by Fusion of a Human-mouse Hybridoma. J. Immunol. Meths. 1984; 70: 83–90
   Google Scholar
• Pierson J., Darley T., Stevenson G. T., Virji M. Monoclonal Immunoglobulin Light Chains in Urine of Patients with Lymphoma. Brit. J. Cancer 1980; 41: 681–688
   Google Scholar
• Stevenson F. K., Spellerberg M., Smith J. L. Monoclonal Immunoglobulin Light Chain in Urine of Patients with B Lymphocytic Disease: Its Source and Use as a Diagnostic Aid. Brit. J. Cancer 1983; 47: 607–612
   PubMed Web of Science ®Google Scholar
• Tutt A. L., Stevenson F. K., Smith J. L., Stevenson G. T. Antibodies Against Urinary Light Chain Idiotypes as Agents for Detection and Destruction of Human Neoplastic B Lymphocytes. J. Immunol. 1983; 131: 3058–3063
   Google Scholar
• Stevenson F. K., Elliott E. V., Stevenson G. T. Some Effects on Leukaemic B Lymphocytes of Antibodies to Defined Regions of Their Surface Immunoglobulin. Immunology 1977; 32: 549
   Google Scholar
• Stevenson G. T., Elliott E. V., Stevenson F. K. Idiotypic Determinants on the Surface Immunoglobulin of Neoplastic Lymphocytes: A Therapeutic Target. Fed. Proc. 1977; 36: 2268–2271
   PubMedGoogle Scholar
• Rankin E. M., Hekman A. Mouse Monoclonal Antibodies Against the Idiotype of Human B-Cell Non-Hodgkin's Lymphomas: Production, Characterization and Use to Monitor the Progress of Disease. Eur. J. Immunol. 1984; 14: 1119–1126
   Google Scholar
• Tutt A. L., Stevenson F. K., Slavin S., Stevenson G. T. Secretion of Idiotypic IgM by the Mouse B-Cell Leukaemia (BCL1) Occurs Spontaneously in Vitro and in Vivo. Immunology 1985; 55: 59–63
   PubMedGoogle Scholar
• Boyse E. A., Old L. J. Some Aspects of Normal and Abnormal Cell Surface Genetics. Ann. Rev. Genetics 1969; 3: 269–290
   Web of Science ®Google Scholar
• Stevenson F. K., Gordon J. Immunization with Idiotypic Immunoglobulin Protects Against Development of B Lymphocytic Leukaemia, but Emerging Tumor Cells can Evade Antibody Attack by Modulation. J. Immunol. 1983; 130: 970–973
   PubMed Web of Science ®Google Scholar
• Glennie M. J., Stevenson G. T. Univalent Antibodies Kill Tumour Cells in vitro and in vivo. Nature 1982; 295: 712–714
   PubMed Web of Science ®Google Scholar
• Stevenson G. T., Glennie M. J., Gordon J. The Killing of Lymphoma Cells by Univalent Derivatives of Tumor-Specific Antibody. UCLA Symposia on Molecular and Cellular Biology 1982; 24: 459–472
   Google Scholar
• Parham P. On the Fragmentation of Monoclonal IgGl, IgG2a and IgG2b from Balb/c mice. J. Immunol. 1983; 131: 2895–2902
   PubMed Web of Science ®Google Scholar
• Stevenson G. T., Glennie M. J., Paul F. E., Stevenson F. K., Watts H. F., Wyeth P. Preparation and Properties of Fab IgG, a Chimeric Univalent Antibody Designed to Attack Tumor Cells. Bioscience Reports 1985; 5: 991–998
   PubMed Web of Science ®Google Scholar
• Stevenson G. T., Cole V. M., Summerton J., Watts H. F. Chimeric Univalent Antibodies for Treating Lymphoid Malignancies. Medical Oncology and Tumor Pharmacotherapy 1984; 1: 275–278
   Google Scholar
• Cobbold S. P., Waldmann H. Therapeutic Potential of Monoclonal Antibodies. Nature 1984; 308: 460–462
   Google Scholar
• Milstein C., Cuello A. C. Hybrid Hybridomas and Their Use in Immunohistochemistry. Nature 1983; 305: 537–540
   PubMed Web of Science ®Google Scholar
• Ochi A., Hawley R. G., Hawley T., Shulman M. J., Trannecker A., Kohler G., Hozumi N. Functional Immunoglobulin M Production after Transfection of Cloned Immunoglobulin Heavy and Light Genes into Lymphoid Cells. Proc. Natl. Acad. Sci. 1983; 80: 6351–6355
   PubMed Web of Science ®Google Scholar
• Oi V. T., Morrison S. L., Herzenberg L. A., Berg P. Immunoglobulin Gene Expression in Transformed Lymphoid Cells. Proc. Natl. Acad. Sci. 1983; 80: 825–829
   PubMed Web of Science ®Google Scholar
• Neuberger M. S., Williams G. T., Fox R. O. Recombinant Antibodies Possessing Novel Effector Functions. Nature 1984; 312: 604–608
   PubMed Web of Science ®Google Scholar
• Sharon J., Gefter M. L., Manser T., Morrison S. L., Oi V. T., Ptashne M. Expression of a VHCK Chimeric Protein in Mouse Myeloma Cells. Nature 1984; 309: 364–367
   Google Scholar
• Boulianne G. L., Hozumi N., Shulman M. J. Production of Functional Chimeric Mouse/Human Antibody. Nature 1984; 312: 643–646
   PubMed Web of Science ®Google Scholar
• Morrison S. L., Johnson M. J., Herzenberg L. A., Oi V. T. Chimeric Human Antibody Molecules: Mouse Antigen-Binding Domains with Human Constant Region Domains. Proc. Natl. Acad. Sci. 1984; 81: 6851–6855
   PubMed Web of Science ®Google Scholar
• Krolick K. A., Uhr J. W., Slavin S., Vitetta E. S. In vivo Therapy of a Murine B Cell Tumor (BCL1) Using Antibody-ricin A Chain Immunotoxins. J. Exp. Med. 1982; 155: 1797–1809
   PubMed Web of Science ®Google Scholar
• Krolick K. A., Uhr J. W., Vitetta E. S. Selective Killing of Leukaemia Cells by Antibody-Toxin Conjugates: Implications for Autologous Bone Marrow Transplantation. Nature 1982; 295: 604–605
   PubMedGoogle Scholar
• McGaughey C. Feasibility of Tumor Immunoradiotherapy Using Radioiodinated Antibodies to Tumor-Specific Cell Membrane Antigens with Emphasis on Leukemias and Early Metastases. Oncology 1974; 29: 302–319
   Google Scholar
• Hurwitz E., Kashi R., Burowsky D., Arnon R., Haimovich J. Site-Directed Chemotherapy with a Drug Bound to Anti-Idiotypic Antibody to a Lymphoma Cell-Surface IgM. Int. J. Cancer 1983; 31: 745–748
   Google Scholar
• Glennie M. J., Stevenson G. T. Derivatives of Anti-Idiotype Antibodies in the Treatment of B Cell Lymphoma. Adv. Exp. Med. Biol. 1985; 186: 843–853
   Google Scholar
• Lanier L. L., Babcock G. F., Raybourne R. B., Arnold L. W., Warner N. L., Haughton G. Mechanism of B Cell Lymphoma Immunotherapy with Passive Xenogenic Anti-Idiotype Serum. J. Immunol. 1980; 125: 1730–1736
   PubMed Web of Science ®Google Scholar
• Kassel R. L., Old L. J., Carswell E., Fiore N., Hardy W. D. Serum-Mediated Leukaemia Cell Destruction in AKR Mice. Role of Complement in the Phenomenon. J. Exp. Med. 1973; 138: 925–938
   PubMed Web of Science ®Google Scholar
• Bernstein I. D., Tam M. R., Nowinski R. C. Mouse Leukemia: Therapy with Monoclonal Antibodies Against a Thymus Differentiation Antigen. Science 1980; 207: 68–71
   PubMed Web of Science ®Google Scholar
• Raffeld M., Neckers L., Longo D. L., Cossman J. Spontaneous Alteration of Idiotype in a Monoclonal B-Cell Lymphoma. N. Engl. J. Med. 1985; 312: 1653–1658
   PubMed Web of Science ®Google Scholar
• Krikorian J. G., Portlock C. S., Cooney P., Rosenberg S. A. Spontaneous Regression of Non-Hodgkin's Lymphoma: A Report of Nine Cases. Cancer 1979; 46: 2093–2099
   Google Scholar
• Hawrylowicz C. M., Reese R. C., Hancock B. W., Potter C. W. Depressed Spontaneous Natural Killing and Interferon Augmentation in Patients with Malignant Lymphoma. Eur. J. Cancer Clin. Oncol. 1982; 18: 1081–1088
   PubMedGoogle Scholar
• Abbas A. K., Burakoff S. J., Gefter M. L., Greene M. I. T Lymphocyte-mediated Suppression of Myeloma Function in vitro. III. Regulation of Antibody Production in Hybrid Myeloma Cells by T Lymphocytes. J. Exp. Med. 1980; 152: 969
   Google Scholar
• Milburn G. L., Parslow T. G., Goldenberg C., Granner D. K., Lynch R. G. Idiotype-specific T Cell Suppression of Light Chain mRNA Expression in MOPC 315 Cells is Accompanied by a Posttranscriptional Inhibition of Heavy Chain Expression. J. Mol. Cell. Immunol., 1: 115–123
   Google Scholar
• Abbas A. K., Perry L. L., Bach B. A., Greene M. I. Idiotype-specific T Cell Immunity. I. Generation of Effector and Suppressor T Lymphocytes Reactive with Myeloma Idiotypic Determinants. J. Immunol. 1980; 124: 1160–1166
   Google Scholar
• Nisonoff A., Bangasser S. Immunological Suppression of Idiotypic Specificities. Transplant Rev. 1975; 27: 100–134
   Google Scholar
• Kresina T. F., Baine Y., Nisonoff A. Adoptive Transfer of Resistance to Growth of an Idiotype-secreting Hybridoma by T Cells from Idiotypically Suppressed Mice. J. Immunol. 1983; 130: 1478–1482
   PubMedGoogle Scholar
• Owen F. L., Ju Shyr-Te, Nisonoff A. Binding to Idiotypic Determinants of Large Proportions of Thymus-Derived Lymphocytes in Idiotypically Suppressed Mice. Proc. Natl. Acad. Sci. 1977; 74: 2084–2088
   Google Scholar
• Fesno M., Nabel G., McVay-Bondreau L., Furthmayer H., Cantor H. Antigen-specific T Lymphocyte Clones. I. Characterization of a T Lymphocyte Clone Expressing Antigen-specific Suppressive Activity. J. Exp. Med. 1981; 153: 1246–1259
   Google Scholar
• Lamb J. R., Feldmann M. A Human Suppressor T Cell Clone Which Recognizes an Autologous Helper T Cell Clone. Nature 1982; 300: 456–458
   Google Scholar
• Bensussan A., Acuto O., Hussey R. E., Milanese C., Reinherz E. L. T3-Ti Receptor Triggering of T8+ Suppressor T Cells Leads to Unresponsiveness to Interleukin-2. Nature 1984; 311: 565–567
   Google Scholar
• Zanders E. D., Feldmann M., Green N., Lamb J. R. Direct Evaluation of Antigen Binding to Human T Lymphocyte Clones: Involvement of Major Histocompatibility Complex Products in Antigen Binding. Eur. J. Immunol. 1984; 14: 1101–1105
   Google Scholar
• Navarro R. F., Jalkanen S. T., Hsu M., Spenderstrup-Hansen G., Goronzy J., Weyand C., Fathman C. G., Clayberger C., Krensky A. M., Butcher E. C. Human T Cell Clones Express Functional Homing Receptors Required for Normal Lymphocyte Trafficking. J. Exp. Med. 1985; 162: 1075–1080
   Google Scholar